Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Bird Flu

<< Previous

Bullboard Posts

Next >>

Comment by menoalittleon Jun 17, 2024 12:51pm

141 Views

Post# 36092312

RE:RE:RE:RE:Bird Flu

>> A grant would be most welcome. But don't those things take forever to work out?

Unless I'm mistaken, government grants either aren't available or aren't typically given to a publically traded company. Consequently, I'm honestly not expecting one. (Of course, that doesn't mean that I think there's something else brewing. The stock wants to trade up, but someone seems to still be sitting on it for some reason. Guess we'll all know more by the end of the week...)

<< Previous

Bullboard Posts

Next >>

Osisko Development receives permits for Cariboo Gold Project